Sfoglia per AUTORE
CASCAVILLA N
Collezione AOU Novara

  

Items : 12

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):437-442. doi: 10.1007/s00277-023-05577-9. Epub 2023 Dec 7.
2024
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Vannucchi AM; Finazzi MC; Tognoni G; Cattaneo D; Vianelli N; Bellini M; Scaffidi L; Bucelli C; Ramundo F; Lunghi F; Betti S; Gesullo F; Guglielmelli P; Mora B; Cacciola E; Calabresi L; Loscocco GG; Rumi E; Patriarca A; Cascavilla N; Siragusa S; Musolino C; Carli G; Caramella M; Rapezzi D; Ricco A; Pane F; Benevolo G; et alii...

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.
2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Latagliata R; Zini G; D'Errigo MG; Bova I; Delfino IM; Arcadi MT; Cufari P; Rizzo L; Candoni A; Rivellini F; Buccisano F; Stamatoullas-Bastard A; Liberati AM; Impera S; Di Renzo N; Palumbo GA; Fenaux P; Ricco A; Germing U; Molteni A; Bocchia M; Beltrami G; Castelli A; Fattizzo B; Iannì G; Russo E; Guarini A; Tripepi G; Ferrero D; et alii...

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera. in NEJM evidence / NEJM Evid. 2023 Jun;2(6):EVIDoa2200335. doi: 10.1056/EVIDoa2200335. Epub 2023 May 15.
2023
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Tognoni G; Bellini M; Finazzi MC; Bucelli C; Vianelli N; Lunghi F; Scaffidi L; Betti S; Gesullo F; Guglielmelli P; Loscocco GG; Mannarelli C; Cacciola E; Mora B; Cascavilla N; Rumi E; Patriarca A; Musolino C; Siragusa S; Carli G; Caramella M; Rapezzi D; Pane F; Ricco A; Benevolo G; Iurlo A; Palandri F; Bonifacio M; et alii...

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Martinelli G; Rossi G; Volpi R; Sciumè M; Tarella C; Marconi G; Federico V; Romano A; Cardinali V; Gigli F; Roncoroni E; Ferrara F; Maurillo L; Nanni J; Rivellini F; Cascavilla N; Fianchi L; Cilloni D; Lanza F; Abruzzese E; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Basilico CM; Manfra I; et alii...

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.
2021
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Finazzi MC; Tognoni G; Bucelli C; Vianelli N; Bellini M; Scaffidi L; Lunghi F; Betti S; Guglielmelli P; Mannarelli C; Loscocco GG; Mora B; Cacciola E; Cascavilla N; Patriarca A; Siragusa S; Rumi E; Rapezzi D; Musolino C; Caramella M; Carli G; Benevolo G; Pane F; Ricco A; Palandri F; Iurlo A; Ciceri F; Bonifacio M; et alii...

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2021 Mar;62(3):669-678. doi: 10.1080/10428194.2020.1838509. Epub 2020 Nov 6.
2021
AOU Novara

Rosti G; Castagnetti F; Baccarani M; Vignetti M; Di Renzo N; Sorà F; Miggiano MC; Saussele S; Sztankay M; Albano F; Kota V; Oerlemans S; Cascavilla N; Okumura I; Breccia M; Cottone F; Abruzzese E; Wan C; Caocci G; Blijlevens NMA; Capodanno I; Elena C; Bonifacio M; Ector G; Stagno F; Bee PC; Patriarca A; Efficace F; Iurlo A; et alii...

2021
AOU Città della Salute di Torino
AOU Novara

Liberati AM; Novak U; Osborne W; Frezzato M; Fox CP; Davies A; Cascavilla N; Bernardi M; Gastaldi E; Cozens K; Bromberg JEC; Singh V; Fanni A; Re F; Patti C; McKay P; Olivieri J; Linton K; Nassi L; Cellini C; Botto B; Cattaneo C; Khwaja J; Luppi M; Calimeri T; Doorduijn JK; Re A; Cabras MG; Smith J; et alii...

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs. in Haematologica / Haematologica. 2020 Jan;105(1):193-200. doi: 10.3324/haematol.2019.219139. Epub 2019 Jun 20.
2020
AOU Città della Salute di Torino
AOU Novara

Corradini P; Cavo M; Offidani M; Liberati AM; Sonneveld P; Hajek R; Nagler A; Ben-Yehuda D; Cascavilla N; Nozzoli C; Ballanti S; Galieni P; Patriarca F; Musto P; Musolino C; Ribolla R; De Paoli L; Di Raimondo F; Spada S; Boccadoro M; Gay F; Montefusco V;

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. in Leukemia / Leukemia. 2020 Feb;34(2):488-498. doi: 10.1038/s41375-019-0563-0. Epub 2019 Sep 2.
2020
AOU Città della Salute di Torino
AOU Novara

Rosti G; Binotto G; Vignetti M; Bergamaschi M; Fozza C; Cascavilla N; Saussele S; Pregno P; Gozzini A; Patriarca A; Capodanno I; Martino B; Tiribelli M; Crugnola M; Caocci G; Castagnetti F; Abruzzese E; Cottone F; Bonifacio M; Breccia M; Iurlo A; Efficace F; Stagno F;

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19
2018
AOU Città della Salute di Torino
AOU Novara

Gay F; Petrucci MT; Boccadoro M; Offidani M; Palumbo A; Corradini P; Musto P; Tacchetti P; Nagler A; Benevolo G; Ria R; Caravita T; Cangialosi C; Marcatti M; Ponticelli E; Baldini L; Rocco S; Cascavilla N; Rizzi R; Angelucci E; Nozzoli C; Oddolo D; Ben-Yehuda D; Guglielmelli T; Mina R; Crippa C; Patriarca F; Spada S; De Paoli L; et alii...

Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study. in Drug design, development and therapy / Drug Des Devel Ther. 2015 May 18;9:2687-94. doi: 10.2147/DDDT.S79576. eCollection 2015.
2015
AOU Novara

Cascavilla N; De Stefano V; Pane F; Pancrazzi A; Iurlo A; Gobbi M; Palandri F; Specchia G; Liberati AM; D'Adda M; Gaidano G; Fjerza R; Achenbach H; Smith J; Wilde P; Vannucchi AM;

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.
2014
AOU Novara

Cortelezzi A; Sciumè M; Liberati AM; Vincenti D; Cuneo A; Reda G; Laurenti L; Zaja F; Marasca R; Chiarenza A; Gritti G; Orsucci L; Storti S; Angelucci E; Cascavilla N; Gobbi M; Mauro FR; Morabito F; Fabris S; Piciocchi A; Vignetti M; Neri A; Rossi D; Giannarelli D; Guarini A; Foà R;